Source link : https://www.newshealth.biz/health-news/slowing-of-peripheral-artery-disease-another-liraglutide-benefit/
Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes on subcutaneous liraglutide had a significantly greater increase of transcutaneous oxygen pressure (TcPO2) compared with conventional treatment (14.2 mmHg vs 2.9 mmHg, estimated treatment difference 11.2 […]
Author : News Health
Publish date : 2024-03-13 17:16:42
Copyright for syndicated content belongs to the linked Source.
in Health